Sanara MedTech Inc.SMTINASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
143.48%
↑ 181% above average
Average (39q)
-176.31%
Historical baseline
Range
High:1152.63%
Low:-5514.01%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 143.48% |
| Q2 2025 | 43.90% |
| Q1 2025 | -127.78% |
| Q4 2024 | 47.06% |
| Q3 2024 | 17.07% |
| Q2 2024 | -95.24% |
| Q1 2024 | -655.40% |
| Q4 2023 | 78.62% |
| Q3 2023 | 40.91% |
| Q2 2023 | -57.14% |
| Q1 2023 | 90.07% |
| Q4 2022 | -642.11% |
| Q3 2022 | 54.76% |
| Q2 2022 | -2.44% |
| Q1 2022 | 12.77% |
| Q4 2021 | -74.07% |
| Q3 2021 | -68.75% |
| Q2 2021 | 5.88% |
| Q1 2021 | -329.29% |
| Q4 2020 | 78.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 40.00% |
| Q1 2020 | -30.43% |
| Q4 2019 | 34.29% |
| Q3 2019 | -133.33% |
| Q2 2019 | -108.33% |
| Q1 2019 | 65.71% |
| Q4 2018 | -229.15% |
| Q3 2018 | -738.00% |
| Q2 2018 | 112.71% |
| Q1 2018 | -117.11% |
| Q4 2017 | 1152.63% |
| Q3 2017 | -241.42% |
| Q2 2017 | -15.34% |
| Q1 2017 | -83.41% |
| Q4 2016 | 124.26% |
| Q3 2016 | 111.54% |
| Q2 2016 | -5514.01% |
| Q1 2016 | 103.74% |
| Q4 2015 | -147.06% |